{"schema_version":"secwatch.filing_event.v1","accession":"0001964738-26-000045","form_type":"8-K","ticker":"SOLV","cik":"0001964738","company_name":"Solventum Corp","filed_at":"2026-08-05T20:17:48+00:00","discovered_at":"2026-08-05T20:19:02.170553+00:00","generated_at":"2026-08-05T20:20:11.546500+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Solventum Q2 sales up 9.5% organic; adj. EPS $2.55 (+50.9%); plans to separate HIS segment","bullets":["Sales $2.2B, organic +9.5%; GAAP EPS $0.53, adjusted EPS $2.55 (+50.9% YoY).","Operating cash flow $227M, free cash flow $144M (+144% YoY).","Announces intent to separate Health Information Systems business segment.","Raises full-year 2026 guidance for organic sales growth, adjusted EPS, and free cash flow.","CEO Bryan Hanson cites strong execution and transformation progress."],"urls":{"canonical":"https://secwatch.observer/filing/0001964738-26-000045","json":"https://secwatch.observer/filing/0001964738-26-000045.json","markdown":"https://secwatch.observer/filing/0001964738-26-000045.md","text":"https://secwatch.observer/filing/0001964738-26-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1964738/000196473826000045/0001964738-26-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1964738/000196473826000045/solv-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:20:11.546500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}